Authors: Wilcox, ME Yang, WQ Senger, D Rewcastle, NB Morris, DG Brasher, PMA Shi, ZQ Johnston, RN Nishikawa, S Lee, PWK Forsyth, PA

Citation: Me. Wilcox et al., Reovirus as an oncolytic agent against experimental human malignant gliomas, J NAT CANC, 93(12), 2001, pp. 903-912

Authors: Duggan, MA Brasher, PMA

Citation: Ma. Duggan et Pma. Brasher, Accuracy of Pap tests reported as CINI, DIAGN CYTOP, 21(2), 1999, pp. 129-136

Authors: Price, A Shi, QA Morris, D Wilcox, ME Brasher, PMA Rewcastle, NB Shalinsky, D Zou, H Appelt, K Johnston, RN Yong, VW Edwards, D Forsyth, P

Citation: A. Price et al., Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340, CLIN CANC R, 5(4), 1999, pp. 845-854

Authors: Hao, D DiFrancesco, LM Brasher, PMA deMetz, C Fulton, DS DeAngelis, LM Forsyth, PAJ

Citation: D. Hao et al., Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from1975 to 1996, ANN ONCOL, 10(1), 1999, pp. 65-70

Authors: Scott, JN Rewcastle, NB Brasher, PMA Fulton, D MacKinnon, JA Hamilton, M Cairncross, JG Forsyth, P

Citation: Jn. Scott et al., Which glioblastoma multiforme patient will become a long-term survivor? A population-based study, ANN NEUROL, 46(2), 1999, pp. 183-188

Authors: Forsyth, PA Wong, H Laing, TD Rewcastle, NB Morris, DG Muzik, H Leco, KJ Johnston, RN Brasher, PMA Sutherland, G Edwards, DR

Citation: Pa. Forsyth et al., Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas, BR J CANC, 79(11-12), 1999, pp. 1828-1835